Rapid responses of catecholamines, natriuretic peptides and inflammatory markers to acute type B aortic dissection (NeuroendOcrine horMone release in acute type b Aortic Dissection [NOMAD] Study). [PDF]
Lim ETA +5 more
europepmc +1 more source
Therapeutic Plasma Exchange in Postural Tachycardia Syndrome (POTS). [PDF]
Baykara Y, Akgun Y.
europepmc +1 more source
[Experience with topical brimonidine (Alphagan (R) 0,2%) in the treatment of glaucomas]
Purpose: The main purpose of our study was to assess the systemic safety of brimonidine tartrate 0.2 %, an alpha 2 highly selective agonist in patients with glaucoma or ocular hypertension Material-Methods: Brimonidine was administered alone or in ...
Dutrieux, C, Detry-Morel, M.
core
Underuse of Pharmacologic Therapies for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Before Specialist Evaluation. [PDF]
Grach SL +7 more
europepmc +1 more source
Hyperadrenergic Postural Tachycardia Syndrome: Clinical Biomarkers and Response to Guanfacine. [PDF]
Okamoto LE +11 more
europepmc +1 more source
A Case of Labile BP in a Patient With Oropharyngeal Carcinoma. [PDF]
Golbin JM +4 more
europepmc +1 more source
From woozy to well: a primary care approach to orthostatic hypotension. [PDF]
He H, Yang C, How CH, Quah JHM.
europepmc +1 more source
Traitement des glaucomes par la brimonidine (Alphagan 0.2%).
PURPOSE: The main purpose of our study was to assess the systemic safety of brimonidine tartrate 0.2%, an alpha 2 highly selective agonist in patients with glaucoma or ocular hypertension Material-Methods: Brimonidine was administered alone or in ...
Dutrieux, C, Detry-Morel, M.
core
Current Management of Resistant Hypertension in Patients with Intracerebral Hemorrhage. [PDF]
Nguyen M +4 more
europepmc +1 more source

